Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.5 HKD | -0.98% | +3.45% | -5.26% |
04-30 | Innovent Biologics, Inc. Reports Revenue Results for the First Quarter of 2024 | CI |
04-30 | Innovent Biologics, Inc. Appoints Samuel Zhang as Global Chief Business Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.26% | 8.5B | |
-3.89% | 88.14B | |
+1.45% | 40.51B | |
-14.46% | 31.67B | |
+51.20% | 24.62B | |
-14.80% | 15.65B | |
-13.98% | 12.07B | |
-7.87% | 11.97B | |
-39.40% | 11.61B | |
+5.62% | 8.81B |
- Stock Market
- Equities
- 1801 Stock
- News Innovent Biologics, Inc.
- Innovent Biologics Logs 1 Billion Yuan in Q4 Revenue